Submission Details
| 510(k) Number | K220681 FDA.gov |
| FDA Decision | Cleared SESE |
| Date Received | March 08, 2022 |
| Decision Date | September 22, 2022 |
| Days to Decision | 198 days |
| Submission Type | Traditional |
| Review Panel | Neurology (NE) |
| Summary | Summary PDF |
K220681 is an FDA 510(k) clearance for the Talee, Talee PostOP, a Orthosis, Cranial (Class II — Special Controls, product code MVA), submitted by Invent Medical USA, LLC (Warminster, US). The FDA issued a Cleared decision on September 22, 2022, 198 days after receiving the submission on March 8, 2022. This device falls under the Neurology review panel. Regulated under 21 CFR 882.5970.
| 510(k) Number | K220681 FDA.gov |
| FDA Decision | Cleared SESE |
| Date Received | March 08, 2022 |
| Decision Date | September 22, 2022 |
| Days to Decision | 198 days |
| Submission Type | Traditional |
| Review Panel | Neurology (NE) |
| Summary | Summary PDF |
| Product Code | MVA — Orthosis, Cranial |
| Device Class | Class II — Special Controls |
| CFR Regulation | 21 CFR 882.5970 |